We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Sean Michael Kelly is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2013 — 2015 |
Kelly, Sean Michael |
F30Activity Code Description: Individual fellowships for predoctoral training which leads to the combined M.D./Ph.D. degrees. |
Genetic Control of Chandelier Interneuron Specification in Cerebral Cortex @ Cold Spring Harbor Laboratory
DESCRIPTION (provided by applicant): Neuronal firing activity within the cerebral cortex is regulated by a diverse assortment of inhibitory GABAergic interneurons, which are able to finely tune circuit activity through a vast array of morphological, molecular, synaptic, and electrophysiological properties. Intrinsic genetic programs and extrinsic experience- driven learning are both likely to play a role in defining different neuronal subtypes and distributing these cells to layers and regions throughout the brain in the proper density to allow formation of meaningful circuit motifs. To approach a complete understanding of interneuron development, the next challenge is to characterize the entire life history of a bona-fide interneuron subtype such as the chandelier cell, arguably the most distinct and uniform GABAergic interneuron yet to be described. Chandelier cells have an unmistakable axon arbor of hundreds of vertically arranged cartridge synapses, each of which specifically innervates the axon initial segment of a pyramidal cell, the site where action potentials are generated. A single chandelier cell can rapidly impact the firing of large groups of excitatory cells in critical cortical layers, while spcific deficits in chandelier cell boutons occur in the brains of schizophrenia patients, further highlighting their importance. We recently characterized the spatial and temporal origin of chandelier cells in mice, demonstrating that these cells originate in a previously uncharacterized domain bordering the lateral ventricle that we have termed the ventral germinal zone (VGZ). The goal of this proposal is to discover the impact of progenitor cell genetic programs and birth timing on chandelier cell distribution and specification in key regions of the cerebral cortex. We propose to combine cre-dependent reporters with inducible knock-in cre drivers of developmental transcription factors in order to fate map chandelier cells to the amygdala, neocortex, and hippocampus in the developing rodent brain in vivo. Furthermore, we propose to combine cre and flippase lines in genetic intersectional strategies to target neuron-generating cell divisions of radial glial stem cells and intermediate progenitor cells with unprecedented temporal specificity. These experiments will effectively mark chandelier cells at the time of birth and allow the tracking of their trajectory into the cortex, where they are assembled into specific cortical layers. The timing and location of progenitor cell divisions are carefully orchestrated during development, an important process that sets the stage for interneuron-pyramidal cell synapse formation. These approaches will ideally provide an unparalleled example of how a specific type of neuron is produced and appropriately dispatched into the cortex for integration into neuronal circuitry. By studying these events, we hope to begin to understand how disordered neuronal connectivity ultimately manifests as debilitating cognitive and behavioral disturbances in schizophrenia, an illness that afflicts more than 1% of the general population.
|
1.009 |